Sham | Heart Failure | Clenbuterol | Metoprolol | Clen + Meto | |
---|---|---|---|---|---|
TUNEL (%) | 0.2 ± 0.1 | 21 ± 4.1† | 11 ± 2.6†, ‡ | 12 ± 3.6†, ‡ | 8.2 ± 1.9*, ‡ |
8-OxoG (%) | 0.5 ± 0.1 | 18 ± 3.9† | 10 ± 2.1†, ‡ | 12 ± 2.6†, ‡ | 5 ± 1.6*, ‡, ∥ |
Human MutY homolog (score)a | 0.6 ± 0.2 | 1.4 ± 0.5 | 2.8 ± 0.5†, § | 2.6 ± 0.4†, § | 3.2 ± 0.6†, ‡ |
8-OxoG glycosylase (%) | 0.2 ± 0.1 | 0.5 ± 0.1 | 8.2 ± 2.2†, ‡ | 6.4 ± 1.5†, § | 13 ± 3.6†, ‡, ∥ |
↵* p < 0.01 vs. Sham.
↵† p < 0.001 vs. Sham.
↵‡ p < 0.001 vs. heart failure.
↵§ p < 0.01 vs. heart failure.
↵∥ p < 0.01 vs. clenbuterol and metoprolol.
↵ a Scoring system for human MutY homolog nuclear and cytoplasmic staining: 0 = 0%; 1 = 0 to 15%; 2 = 15 to 30%; 3 = 30 to 50%; and 4 = >50% positive.